Tsunoda; Hiroyuki
Patent Applications and Registrations
Patent applications and USPTO patent grants for Tsunoda; Hiroyuki.The latest application filed is for "antibody molecules".
Company Profile
6.38.61
- Tsunoda; Hiroyuki - Shizuoka JP
- Tsunoda; Hiroyuki - Gotemba JP
- TSUNODA; Hiroyuki - Gotemba-shi Shizuoka
- Tsunoda; Hiroyuki - Tokyo JP
- Tsunoda; Hiroyuki - Ibaraki JP
- Tsunoda; Hiroyuki - Kodaira JP
- Tsunoda; Hiroyuki - Kodaira-shi JP
- Tsunoda, Hiroyuki - Niihari-gun JP
Patent Activity
| Patent | Date |
|---|---|
| Antibody Molecules App 20220306755 - Igawa; Tomoyuki ; et al. | 2022-09-29 |
| Methods For Producing Polypeptides By Regulating Polypeptide Association App 20220267822 - Igawa; Tomoyuki ; et al. | 2022-08-25 |
| Substrate, structure, structure-manufacturing method, cell-sorting method, cell-manufacturing method, and secretion-producing method Grant 11,359,175 - Ohsaka , et al. June 14, 2 | 2022-06-14 |
| Method of modifying isoelectric point of antibody via amino acid substitution in CDR Grant 11,248,053 - Igawa , et al. February 15, 2 | 2022-02-15 |
| Antibody Molecules App 20220041741 - Igawa; Tomoyuki ; et al. | 2022-02-10 |
| Methods for producing polypeptides by regulating polypeptide association Grant 11,168,344 - Igawa , et al. November 9, 2 | 2021-11-09 |
| Methods For Controlling Blood Pharmacokinetics Of Antibodies App 20210324109 - Igawa; Tomoyuki ; et al. | 2021-10-21 |
| Anti-il-6 Receptor Antibody App 20210206862 - Igawa; Tomoyuki ; et al. | 2021-07-08 |
| Methods for controlling blood pharmacokinetics of antibodies Grant 11,046,784 - Igawa , et al. June 29, 2 | 2021-06-29 |
| Methods of modifying antibodies for purification of bispecific antibodies Grant 10,934,344 - Igawa , et al. March 2, 2 | 2021-03-02 |
| Antiplexin A1 Agonist Antibody App 20200276302 - Kumanogoh; Atsushi ; et al. | 2020-09-03 |
| Antibody Molecules App 20200231688 - Igawa; Tomoyuki ; et al. | 2020-07-23 |
| AntiPlexin A1 agonist antibody Grant 10,688,178 - Kumanogoh , et al. | 2020-06-23 |
| Methods of reducing IL-6 activity for disease treatment Grant 10,662,245 - Igawa , et al. | 2020-05-26 |
| Anti-nr10 Antibody And Use Thereof App 20200002429 - Kuramochi; Taichi ; et al. | 2020-01-02 |
| Anti-il-6 Receptor Antibody App 20190085085 - Igawa; Tomoyuki ; et al. | 2019-03-21 |
| Substrate, Structure, Structure-manufacturing Method, Cell-sorting Method, Cell-manufacturing Method, And Secretion-producing Method App 20180282677 - OHSAKA; Takashi ; et al. | 2018-10-04 |
| Antiplexin A1 Agonist Antibody App 20180193451 - KUMANOGOH; Atsushi ; et al. | 2018-07-12 |
| Methods for producing polypeptides by regulating polypeptide association Grant 10,011,858 - Igawa , et al. July 3, 2 | 2018-07-03 |
| Method Of Modifying Isoelectric Point Of Antibody Via Amino Acid Substitution In Cdr App 20180142027 - Igawa; Tomoyuki ; et al. | 2018-05-24 |
| Methods for Producing Polypeptides by Regulating Polypeptide Association App 20180051307 - Igawa; Tomoyuki ; et al. | 2018-02-22 |
| sc(Fv)2 SITE-DIRECTED MUTANT App 20170342133 - Igawa; Tomoyuki ; et al. | 2017-11-30 |
| Method of modifying isoelectric point of antibody via amino acid substitution in CDR Grant 9,828,429 - Igawa , et al. November 28, 2 | 2017-11-28 |
| Methods Of Modifying Antibodies For Purification Of Bispecific Antibodies App 20170283483 - Igawa; Tomoyuki ; et al. | 2017-10-05 |
| Method for amplifying cDNA derived from trace amount of sample Grant 9,708,603 - Tsunoda , et al. July 18, 2 | 2017-07-18 |
| Methods of modifying antibodies for purification of bispecific antibodies Grant 9,670,269 - Igawa , et al. June 6, 2 | 2017-06-06 |
| Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient App 20170129950 - SHIRAIWA; Hirotake ; et al. | 2017-05-11 |
| Anti-IL-6 Receptor Antibody App 20170121412 - Igawa; Tomoyuki ; et al. | 2017-05-04 |
| Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient Grant 9,556,264 - Shiraiwa , et al. January 31, 2 | 2017-01-31 |
| Structural isomers of sc(Fv)2 Grant 9,493,569 - Igawa , et al. November 15, 2 | 2016-11-15 |
| Nucleic acids encoding anti-NR10 antibodies Grant 9,399,680 - Kuramochi , et al. July 26, 2 | 2016-07-26 |
| Anti-AXL antibody Grant 9,340,615 - Maeda , et al. May 17, 2 | 2016-05-17 |
| Anti-Glypican-3 Antibody Having Improved Kinetics in Plasma App 20150315278 - IGAWA; Tomoyuki ; et al. | 2015-11-05 |
| Method of Modifying Isoelectric Point of Antibody Via Amino Acid Substitution in CDR App 20150284465 - Igawa; Tomoyuki ; et al. | 2015-10-08 |
| Anti-Glypican 3 Antibody App 20150259417 - Nakano; Kiyotaka ; et al. | 2015-09-17 |
| Method of modifying isoelectric point of antibody via amino acid substitution in CDR Grant 9,096,651 - Igawa , et al. August 4, 2 | 2015-08-04 |
| Anti-nr10 Antibody And Use Thereof App 20150175704 - Kuramochi; Taichi ; et al. | 2015-06-25 |
| Antibody Molecules That Bind To Il-6 Receptor App 20150166666 - Igawa; Tomoyuki ; et al. | 2015-06-18 |
| Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient App 20150110793 - Shiraiwa; Hirotake ; et al. | 2015-04-23 |
| METHOD FOR AMPLIFYING cDNA DERIVED FROM TRACE AMOUNT OF SAMPLE App 20150024959 - Tsunoda; Hiroyuki ; et al. | 2015-01-22 |
| Cell Collection System App 20140065704 - Shirai; Masataka ; et al. | 2014-03-06 |
| Anti-nr10 Antibody And Use Thereof App 20140039165 - Kuramochi; Taichi ; et al. | 2014-02-06 |
| Anti-IL-6 Receptor Antibody App 20130317203 - Igawa; Tomoyuki ; et al. | 2013-11-28 |
| Degraded TPO agonist antibody Grant 8,586,039 - Tsuchiya , et al. November 19, 2 | 2013-11-19 |
| Degraded Agonist Antibody App 20130295096 - Fukushima; Naoshi ; et al. | 2013-11-07 |
| Anti-glypican-3 Antibody Having Improved Kinetics In Plasma App 20130295612 - IGAWA; Tomoyuki ; et al. | 2013-11-07 |
| Anti-NR10 antibody and use thereof Grant 8,575,317 - Kuramochi , et al. November 5, 2 | 2013-11-05 |
| Antibody molecules that bind to IL-6 receptor Grant 8,562,991 - Igawa , et al. October 22, 2 | 2013-10-22 |
| Anti-glypican-3 antibody having improved kinetics in plasma Grant 8,497,355 - Igawa , et al. July 30, 2 | 2013-07-30 |
| Expression systems using mammalian beta-actin promoter Grant 8,298,816 - Tsunoda , et al. October 30, 2 | 2012-10-30 |
| Antibody Molecules That Bind To Il-6 Receptor App 20120253016 - Igawa; Tomoyuki ; et al. | 2012-10-04 |
| Anti-ganglioside antibodies and compositions Grant 8,257,703 - Irie , et al. September 4, 2 | 2012-09-04 |
| Anti-axl Antibody App 20120121587 - Maeda; Atsuhiko ; et al. | 2012-05-17 |
| Degraded Tpo Agonist Antibody App 20120015436 - Tsuchiya; Masayuki ; et al. | 2012-01-19 |
| Degraded TPO agonist antibody Grant 8,034,903 - Tsuchiya , et al. October 11, 2 | 2011-10-11 |
| Anti-IL-6 Receptor Antibody App 20110245473 - Igawa; Tomoyuki ; et al. | 2011-10-06 |
| Anti-nr10 Antibody And Use Thereof App 20110229459 - Kuramochi; Taichi ; et al. | 2011-09-22 |
| Anti-Mpl antibodies Grant 8,008,073 - Tsunoda , et al. August 30, 2 | 2011-08-30 |
| Anti-MPL antibodies Grant 7,993,642 - Tsunoda , et al. August 9, 2 | 2011-08-09 |
| Anti-nr10 Antibody And Use Thereof App 20110129459 - Kuramochi; Taichi ; et al. | 2011-06-02 |
| Antibody Molecules App 20110098450 - Igawa; Tomoyuki ; et al. | 2011-04-28 |
| Anti-glypican 3 antibody Grant 7,919,086 - Nakano , et al. April 5, 2 | 2011-04-05 |
| Method of Modifying Isoelectric Point of Antibody Via Amino Acid Substitution in CDR App 20110076275 - Igawa; Tomoyuki ; et al. | 2011-03-31 |
| Mutant firefly luciferase Grant 7,915,021 - Tsunoda , et al. March 29, 2 | 2011-03-29 |
| Anti-MPL Antibodies App 20110059488 - Tsunoda; Hiroyuki ; et al. | 2011-03-10 |
| Anti-Glypican 3 Antibody App 20100248359 - Nakano; Kiyotaka ; et al. | 2010-09-30 |
| Anti-glypican-3 Antibody Having Improved Kinetics In Plasma App 20100239577 - Igawa; Tomoyuki ; et al. | 2010-09-23 |
| IgM Production by Transformed Cell and Method of Quantifying the Same App 20100172899 - Irie; Reiko ; et al. | 2010-07-08 |
| Polynucleotides encoding anti-ganglioside antibodies Grant 7,709,615 - Irie , et al. May 4, 2 | 2010-05-04 |
| Methods for Producing Polypeptides by Regulating Polypeptide Association App 20100015133 - Igawa; Tomoyuki ; et al. | 2010-01-21 |
| Methods For Controlling Blood Pharmacokinetics Of Antibodies App 20090324589 - Igawa; Tomoyuki ; et al. | 2009-12-31 |
| Structural Isomers of sc(Fv)2 App 20090297501 - Igawa; Tomoyuki ; et al. | 2009-12-03 |
| Methods Of Modifying Antibodies For Purification Of Bispecific Antibodies App 20090263392 - Igawa; Tomoyuki ; et al. | 2009-10-22 |
| Mutant firefly luciferase App 20090081680 - Tsunoda; Hiroyuki ; et al. | 2009-03-26 |
| sc(Fv)2 SITE-DIRECTED MUTANT App 20090028854 - Igawa; Tomoyuki ; et al. | 2009-01-29 |
| Method for screening colon cancer cells and gene set used for examination of colon cancer App 20090011413 - Ishii; Mie ; et al. | 2009-01-08 |
| Expression Systems Using Mammalian Beta-Actin Promoter App 20080250514 - Tsunoda; Hiroyuki ; et al. | 2008-10-09 |
| Method And Apparatus For Cell Recovery App 20080145932 - Matsumura; Yasuhiro ; et al. | 2008-06-19 |
| Methods for Enhancing Antibody Activity App 20080009038 - Ohtomo; Toshihiko ; et al. | 2008-01-10 |
| Anti-glypican 3 antibody App 20070190599 - Nakano; Kiyotaka ; et al. | 2007-08-16 |
| Gene set used for examination of Colon cancer App 20070148679 - Ishii; Mie ; et al. | 2007-06-28 |
| Antibodies against lesion tissue App 20060235207 - Tsuchiya; Masayuki ; et al. | 2006-10-19 |
| Anti-mpl antibody App 20060222643 - Tsunoda; Hiroyuki ; et al. | 2006-10-05 |
| Container for suspension and filtration of stool App 20060122534 - Matsumura; Yasuhiro ; et al. | 2006-06-08 |
| Method and apparatus for cell recovery App 20050026230 - Matsumura, Yasuhiro ; et al. | 2005-02-03 |
| Degraded agonist antibody App 20040242847 - Fukushima, Naoshi ; et al. | 2004-12-02 |
| Degraded tpo agonist antibody App 20040091475 - Tsuchiya, Masayuki ; et al. | 2004-05-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 